The material has become investigated in the patent literature for its anxiolytic Houses and lessened sedative, hypnotic, and ataxic aspect-effects, but it does not appear to be accredited for health care use. Łukasik-Głebocka et alOnly one pharmacokinetics research showed that a dose of 0.5 mg flubromazolam induced solid sedative effects that las